Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group

Mariana Brandão, Elena Prisciandaro, Eleni Xenophontos, Alessio Vincenzo Mariolo, Amir H. Sadeghi, Andrea Riccardo Filippi, Antonin Lévy, A. Bandura, Caroline Caramella, Chris Dickhoff, Constance de Margerie‐Mellon, Corinne Faivre‐Finn, Daniel Portik, David Sánchez-Lorente, Dirk De Ruysscher, Egbert F. Smit, Élisa Gobbini, Élie Fadel, Enrico Ruffini, Emanuela Olmetto, Francesco Cortiula, Idris Bahce, Ilias Houda, Isabelle Opitz, Jarushka Naidoo, John Edwards, Jordi Remón, José Carlos Benítez, Juan Trujillo, Jules L. Derks, Karim Amrane, Koen J. Hartemink, Konstantinos Stathopoulos, Lizza Hendriks, Manoli Iglesias, Mario Occhipinti, Matthias Gückenberger, Niccolò Giaj‐Levra, Nicolas Girard, Noemı́ Reguart, Olaf Mercier, Paolo Bironzo, Paul Hofman, René Horsleben Petersen, Riccardo De Angelis, Ronan Abgral, Safae Terrisse, Sanjay Popat, T. Pierret, Torsten Blum, Umberto Ricardi, Valeria Dionisi, Thierry Berghmans, Anne‐Marie C. Dingemans